Abacus FCF Innovation Leaders ETF (BATS:ABOT – Get Free Report) was the recipient of a significant growth in short interest in October. As of October 15th, there was short interest totaling 174 shares, a growth of 987.5% from the September 30th total of 16 shares. Based on an average daily volume of 731 shares, the short-interest ratio is currently 0.2 days. Approximately 0.1% of the company’s stock are short sold.
Abacus FCF Innovation Leaders ETF Price Performance
Shares of BATS ABOT traded up $0.30 during trading hours on Monday, hitting $46.71. 78 shares of the stock were exchanged, compared to its average volume of 375. Abacus FCF Innovation Leaders ETF has a one year low of $32.14 and a one year high of $46.71. The company’s 50 day moving average is $44.19 and its 200 day moving average is $38.94. The firm has a market capitalization of $8.17 million, a P/E ratio of 33.48 and a beta of 0.89.
Institutional Trading of Abacus FCF Innovation Leaders ETF
A hedge fund recently bought a new stake in Abacus FCF Innovation Leaders ETF stock. Cetera Investment Advisers acquired a new position in shares of Abacus FCF Innovation Leaders ETF (BATS:ABOT – Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 6,631 shares of the company’s stock, valued at approximately $220,000. Cetera Investment Advisers owned approximately 3.79% of Abacus FCF Innovation Leaders ETF as of its most recent filing with the Securities & Exchange Commission.
About Abacus FCF Innovation Leaders ETF
The Abacus FCF Innovation Leaders ETF (ABOT) is an exchange-traded fund that is based on the FCF US Quality Innovation index. The fund tracks an index that seeks to provide exposure to US all-cap companies with strong free cash flow and R&D investments. ABOT was launched on Dec 7, 2020 and is issued by Abacus.
Read More
- Five stocks we like better than Abacus FCF Innovation Leaders ETF
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Abacus FCF Innovation Leaders ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abacus FCF Innovation Leaders ETF and related companies with MarketBeat.com's FREE daily email newsletter.
